116 related articles for article (PubMed ID: 36301046)
21. Pharmacokinetic interaction between high-dose methotrexate and amoxycillin.
Ronchera CL; Hernández T; Peris JE; Torres F; Granero L; Jiménez NV; Plá JM
Ther Drug Monit; 1993 Oct; 15(5):375-9. PubMed ID: 8249043
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
Wiczer T; Dotson E; Tuten A; Phillips G; Maddocks K
J Oncol Pharm Pract; 2016 Jun; 22(3):430-6. PubMed ID: 26152702
[TBL] [Abstract][Full Text] [Related]
23. Implementation and evaluation of high-dose methotrexate administration guidelines.
Nowak TJ; Lorge AH; Rein LE; Canadeo AM; Frank JP; Samanas LC; Urmanski AM; Atallah EL
J Oncol Pharm Pract; 2019 Oct; 25(7):1675-1681. PubMed ID: 30360674
[TBL] [Abstract][Full Text] [Related]
24. A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography.
Kooiman J; Sijpkens YW; de Vries JP; Brulez HF; Hamming JF; van der Molen AJ; Aarts NJ; Cannegieter SC; Putter H; Swarts R; van den Hout WB; Rabelink TJ; Huisman MV
Nephrol Dial Transplant; 2014 May; 29(5):1029-36. PubMed ID: 24578471
[TBL] [Abstract][Full Text] [Related]
25. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
[TBL] [Abstract][Full Text] [Related]
26. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project.
McKinnon K; Tran T; Lewis V
J Oncol Pharm Pract; 2023 Apr; 29(3):679-684. PubMed ID: 35156868
[TBL] [Abstract][Full Text] [Related]
29. Maintenance Fluid Therapy with Saline, Dextrose-Supplemented Saline or Lactated Ringer in Childhood: Short-Term Metabolic Effects.
Ricciuti A; Milani GP; Tarantino S; Ghilardi R; Lava SAG; Alberzoni M; Bianchetti MG; Agostoni C
Nutrients; 2020 May; 12(5):. PubMed ID: 32429568
[TBL] [Abstract][Full Text] [Related]
30. pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia.
Rojas de Morales T; Navas R; Viera N; Alvarez CJ; Chaparro N; Griman D
Med Oral Patol Oral Cir Bucal; 2007 Oct; 12(6):E435-9. PubMed ID: 17909509
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients.
Sanguanboonyaphong P; Komvilaisak P; Suwannaying K; Yoodee J; Saeteaw M; Chanthawong S; Subongkot S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):93-100. PubMed ID: 35092376
[TBL] [Abstract][Full Text] [Related]
33. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
[TBL] [Abstract][Full Text] [Related]
34. Substitution of sodium acetate for sodium bicarbonate for urine alkalinization in high-dose methotrexate therapy.
Alrabiah Z; Luter D; Proctor A; Bates JS
Am J Health Syst Pharm; 2015 Nov; 72(22):1932-4. PubMed ID: 26541946
[No Abstract] [Full Text] [Related]
35. Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma.
Young EP; Cheng WS; Bernhardt MB; Wang LL; Rainusso N; Foster JH
Pediatr Blood Cancer; 2020 Apr; 67(4):e28123. PubMed ID: 31867853
[TBL] [Abstract][Full Text] [Related]
36. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
[TBL] [Abstract][Full Text] [Related]
37. High dose methotrexate containing regimen in pediatric non-metastatic extremity osteosarcoma patients: experience from a tertiary cancer center in India.
Rajeswari B; Guruprasad CS; Nair M; Prasanth VR; Sugath BS; Thankamony P
Pediatr Hematol Oncol; 2022 Apr; 39(3):225-232. PubMed ID: 34378476
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
[TBL] [Abstract][Full Text] [Related]
39. The Role of Saline and Sodium Bicarbonate Preprocedural Hydration to Prevent Mid-term Renal Insufficiency in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention.
Hagikura A; Goto K; Takebayashi H; Kikuta Y; Kobayashi K; Sato K; Taniguchi M; Hiramatsu S; Kawai Y; Kohno H; Kusuyama T; Haruta S
Intern Med; 2019 Apr; 58(8):1057-1065. PubMed ID: 30568126
[TBL] [Abstract][Full Text] [Related]
40. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
